39 results
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... Treatment • Invasive ... pulmonary aspergillosis ... #management #pharmacology ... #IDSA
Hyperacute Hypoxemia - Workup and Management
Differential Diagnosis: Aspiration, Flash Pulmonary Edema, Mucous Plugging, Bronchospasm, Pulmonary Embolism,
Differential Diagnosis ... Aspiration, Flash Pulmonary ... Bronchospasm, Pulmonary ... #Management #treatment ... #criticalcare
Rodent-associated Bacterial infections: Leptospirosis, Rat-bite fever, Tularemia, Plague 

#rodent
#infections
#leptospirosis
#tularemia
#ratbitefever
#plague
#rats
#infectiousdisease
#fever
#differential
#diagnosis
#management
#treatment
#table
infectiousdisease #fever #differential ... #diagnosis #management ... #treatment #table
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
Shock - Differential ... Diagnosis Framework ... • Obstructive: Pulmonary ... #Diagnosis #criticalcare ... #management
Shock - Differential Diagnosis by Classification

Hypovolemic (Intravascular volume depletion)
 - Hemorrhagic 
   • Trauma
Shock - Differential ... Diagnosis by Classification ... flow) - Massive pulmonary ... #Diagnosis #Classification ... #Table #CriticalCare
Massive Hemoptysis - Differential Diagnosis Framework and Management
Definition: 150-600 mL over 24 hours
Differential Diagnosis:
 • Tracheobronchial:
Diagnosis Framework ... Diagnosis: • ... Primary Vascular: Pulmonary ... #Diagnosis #Management ... #pulmonary #criticalcare
Pulmonary Embolism - Risk Stratification and Prognostication based on scores and clinical features

 • Bova score
Pulmonary Embolism ... Hemodynamics (Stable ... prognostication #diagnosis ... #management #stratification ... #criticalcare #
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Potential Treatment ... infection Episode #Pharmacology ... #Management #CDiff
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
Pericardial tamponade, Pulmonary ... vasoactive drug pharmacology ... #inopressors #diagnosis ... #management #comparison ... #table